The aim of this clinical trial is to study the effect of an intravenous infusion of lidocaïne in a multimodal analgesic protocol on the architecture sleep during the first postoperative night.
To study the effect of lidocaïne, we plan to include 40 patients, randomized in 2 groups, undergoing open prostate surgery in this randomized placebo-controlled trial. Before anesthesia induction, these patients receive an intravenous lidocaine infusion (bolus 1,5 mg.kg-1 followed by a continuous infusion of 2mg.kg-1.h during 24 hours) or an equal volume of placebo. Then the anesthesia is induced with propofol, sufentanil et rocuronium. The postoperative analgesia is provided by paracetamol, tramadol and patient-controlled analgesia (PCA) with morphine or oral oxycodone. A polysomnography is registred on the preoperative night and on the first postoperative night.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
40
Continuous infusion during per and postoperative periods
Continuous infusion during per and postoperative periods
Time ratio between rapid eye movement sleep(REM) + Stage 3 sleep / Stage 1 + Stage 2 sleep
Time frame: Postoperaty day 1
Sleep latence
Time frame: Postoperaty day 1
Sleep time
Time frame: Postoperaty day 1
Cumulative Opioid use
Time frame: Postoperaty day 1
Quality of analgesia (Visual Analogic Scale)
Time frame: Postoperaty day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.